Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pfizer Not Making Pricing Changes, Sees Ways To Work With Trump

Executive Summary

Pfizer CEO Ian Read said during the company’s quarterly call that there are ‘lots of ways’ to work with the new Trump administration, his comments coming on the same day several industry leaders met with the new US president.


Related Content

Stockwatch: Pfizer, Roche, AZ, Novo Prolong Pharmaceutical Winter
Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan
Pfizer Will Support Inflectra Launch With Dedicated Sales Force
Pfizer/Hospira's Biosimilar Pipeline: Substantial Overlap, Limited Divestiture So Far


Related Companies